RMC No. 93-2024 — Publishing the Full Text of the June 20, 2024 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing Updates to the List of VAT-Exempt Products Under Republic Act (R.A.) No. 10963 (TRAIN Law) and R.A. No. 11534 (CREATE Act) Digest | Full Text | Annex A

REPUBLIC OF THE PHILIPPINES DEPARTMENT OF FINANCE BUREAUOF INTERNALREVENUE RECORY XAANA EMENNVSION A# Tn BUREAU OF INTERNAL REVENUE Quezon City AUG 2 8 2024

6

Bringing in Revenues for Nation-buiiding Y AUG 2 7 2024 06T-2 THVE. Ss

REVENUE MEMORANDUM CIRCULAR NO._ 0 9 3 - 2 0 2 4

SUBJECT :Publishing the Full Text of the June 20, 2024 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing

Updates to the List of VAT-Exempt Products Under Republic Act (R.A.) No. 10963 (TRAIN Law) and R.A.No.11534 (CREATE Act)

TO : All Internal Revenue Officers and Others Concerned

For the information and guidance of all internal revenue officers, employees and others concerned, attached is the June 20, 2024 Ietter (Annex "A") from Dr. Samuel A. Zacate,

Under the TRAIN Law and the CREATE Act, particularly the following: Director General of the FDA, for an update to the published List of VAT-Exempt Medicines

1. Inclusion of certain medicines for cancer, high cholesterol, hypertension, and

mental illness; and

2. Deletion of medicines for hypertension.

exemption of the covered medicines and medical devices under the CREATE Act shall be on As clarified under Q&A No. 1 of RMC No. 99-2021, the effectivity of the VAT

the date of publication by the FDA of the updates to the said list.

All concerned are hereby enjoined to be guided accordingly and give this Circular as wide a publicity as possible.

UMAGUI, JR. missioner of Internal Revenue

BUREAU OF INTERNAL REVENUE

InternAl COMMUniCatIOnS DIViSIOn

NYY

AUG 28 222

Y UuIv